1-2 years of biotechnology industry experience. Design with minimal oversight, execute and analyze data from experiments….
From Indeed – 22 Jul 2016 16:22:12 GMT
– View all San Diego jobs
Find out more about this position and several others at BioLegend’s Career Fair on August 6th!
As a member of the Manufacturing Group in the BMIA Department, the Manufacturing Assistant will be responsible for bottling, kit assembly, in process test […
Find out about this position and several others at BioLegend’s Career Fair on August 6th!
The Research Associate – Cell Biology is responsible for quality control of polyclonal and monoclonal antibodies and assists with new product development for C […
Find out more about this position and several others at BioLegend’s Career Fair August 6th!
The successful candidate for the Research Associate position will be involved in developing new products and regents for fluorescence microscopy and flow cyt […
Find out about this position and others at BioLegend’s Career Fair on August 6th!
Exciting Research Associate opportunity that offers significant opportunity for learning and career growth in a fast paced biotechnology company committed to excellenc […
Find out more information about this position and others at BioLegend’s Career Fair on August 6th!
At BioLegend, we are dedicated to developing and commercializing high quality reagents to support the research community. We are currently seeking a h […
Sign up for BioLegend’s Career Fair on August 6th to find out more about this position and several others!
The Cell Culture Development Scientist will take the lead and be responsible for process optimization and scale up of existing hybridoma cell […
SAN DIEGO, July 22, 2016 /PRNewswire/ — Sequenom, Inc. (NASDAQ: SQNM), a life sciences company committed to enabling healthier lives through the development of innovative products and services, today announced it will report financial results for the second quarter 2016 after closing of the NASDAQ Global Market on Wednesday, August 3, 2016.
A conference call hosted by Dr. Dirk van den Boom, President and CEO, and other members of senior management will take place on Wednesday, August 3, at 5:00 p.m. ET (2:00 p.m. PT) and will be webcast live on the Sequenom Website.
Call participants should dial 877-883-0383 (U.S. / Canada) or 412-902-6506 (other countries). Please use code 3179275. A telephonic replay will be available through September 3, 2016 by dialing 877-344-7529 (US toll free), 855-669-9658 (Canada toll free), or 412-317-0088 (international toll), and entering the conference number 10090495.
The conference call webcast is also accessible through the “Invest” section of the Sequenom Website at www.sequenom.com/invest.
Sequenom, Inc. (NASDAQ: SQNM) is committed to enabling healthier lives through the development of innovative products and services. The Company serves patients and physicians by providing early patient management information. To learn how Sequenom is interpreting the genome to improve your life, visit www.sequenom.com.
About Sequenom Laboratories
Sequenom Laboratories, a CAP-accredited and CLIA-certified molecular diagnostics laboratory, has developed a broad range of laboratory tests, with a focus principally on prenatal care. Branded under the names HerediT®, HerediT® UNIVERSAL, MaterniT® GENOME, MaterniT® 21 PLUS, NextView®, SensiGene® and VisibiliT™, these molecular genetic laboratory-developed tests provide early patient management information for obstetricians, geneticists, and maternal fetal medicine specialists. Sequenom Laboratories is changing the landscape in genetic diagnostics using proprietary cutting edge technologies. Visit www.laboratories.sequenom.com and follow @SequenomLabs.
SEQUENOM®, HerediT®, MaterniT® GENOME, MaterniT® 21 PLUS, NextView®, SensiGene®, VisibiliT™ and Sequenom Laboratories™ are trademarks of Sequenom, Inc. All other trademarks and service marks are the property of their respective owners.
SOURCE Sequenom, Inc.
The top news in biotech this week centers around one big job opening: the head seat at Biogen, now that George Scangos has announced plans to leave the company. Who takes the gig, and the strategic…
[[Click headline to continue reading.]]